Initial human experience with Rubidium-82 renal PET/CT imaging

Journal of Medical Imaging and Radiation Oncology

Volumn 58, Issue 1, 2014, Pages 25-31

  Tahari, Abdel K ^a   Bravo, Paco E ^a   Rahmim, Arman ^a   Bengel, Frank M ^b   Szabo, Zsolt ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

compartmental model; renal blood flow; renal PET CT; Rubidium 82 chloride

Indexed keywords

RADIOPHARMACEUTICAL AGENT; RUBIDIUM;

ADULT; ANTIBODY SPECIFICITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; FEMALE; HUMAN; IMAGE ENHANCEMENT; KIDNEY; MALE; METABOLIC CLEARANCE RATE; METABOLISM; MULTIMODAL IMAGING; PHYSIOLOGY; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIOGRAPHY; REFERENCE VALUE; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

ADULT; FEMALE; HUMANS; IMAGE ENHANCEMENT; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MULTIMODAL IMAGING; ORGAN SPECIFICITY; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RUBIDIUM RADIOISOTOPES; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84894281967     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/1754-9485.12079     Document Type: Article

References (25)

1. Weber WA,. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 2005; 46: 983-995.
2. Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R,. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 1993; 11: 2101-2111.
3. Tamaki N, Yonekura Y, Senda M, et al. Myocardial positron computed tomography with 13N-ammonia at rest and during exercise. Eur J Nucl Med 1985; 11: 246-251.
4. Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981; 63: 1259-1272.
5. Bengel FM, Higuchi T, Javadi MS, Lautamäki R,. Cardiac positron emission tomography. J Am Coll Cardiol 2009; 54: 1-15.
6. Alpert NM, Rabito CA, Correia DJ, et al. Mapping of local renal blood flow with PET and H(2)(15)O. J Nucl Med 2002; 43: 470-475.
7. Szabo Z, Xia J, Mathews WB, Brown PR,. Future direction of renal positron emission tomography. Semin Nucl Med 2006; 36: 36-50.
8. Hutchins GD,. What is the best approach to quantify myocardial blood flow with pet? J Nucl Med 2001; 42: 1183-1184.
9. Mullani NA, Ekas RD, Marani S, Kim EE, Gould KL,. Feasibility of measuring first pass extraction and flow with rubidium-82 in the kidneys. Am J Physiol Imaging 1990; 5: 133-140.
10. Tamaki N, Rabito CA, Alpert NM, et al. Serial analysis of renal blood flow by positron tomography with rubidium-82. Am J Physiol 1986; 251 (5 Pt 2): H1024-1030.
11. Tamaki N, Alpert NM, Rabito CA, Barlai-Kovach M, Correia JA, Strauss HW,. The effect of captopril on renal blood flow in renal artery stenosis assessed by positron tomography with rubidium-82. Hypertension 1988; 11: 217-222.
12. Senthamizhchelvan S, Bravo PE, Esaias C, et al. Human biodistribution and radiation dosimetry of 82Rb. J Nucl Med 2010; 51: 1592-1599.
13. Tang J, Bengel F, Rahmim A,. Cardiac motion-corrected quantitative dynamic Rb-82 PET imaging. J Nucl Med 2010; 51 (Suppl 2): 123.
14. Tang J, Rahmim A, Lautamaki R, Lodge MA, Bengel FM, Tsui BM,. Optimized regional myocardial blood flow abnormality detection in dynamic Rb-82 PET. J Nucl Med 2009; 50 (Suppl 2): 467.
15. Shrout PE, Fleiss JL,. Intraclass correlations-uses in assessing rater reliability. Psychol Bull 1979; 86: 420-428.
16. Di Carli MF, Dorbala S, Meserve J, El Fakhri G, Sitek A, Moore SC,. Clinical myocardial perfusion PET/CT. J Nucl Med 2007; 48: 783-793.
17. Vasconcelos VT, Katayama RC, Ribeiro MF, Medina-Pestana JO, Baptista-Silva JC,. Kidney weight and volume among living donors in Brazil. Sao Paulo Med J 2007; 125: 223-225.
18. Miles KA,. Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol 1991; 64: 409-412.
19. Splenser AE, Fisher ND, Danser AH, Hollenberg NK,. Renal plasma flow: glomerular filtration rate relationships in man during direct renin inhibition with aliskiren. J Am Soc Hypertens 2009; 3: 315-320.
20. Yoshida K, Mullani N, Gould KL,. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 1996; 37: 1701-1712.
21. Lautamaki R, George RT, Kitagawa K, et al. Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: validation in a canine model of coronary artery stenosis. Anglais 2009; 36: 576-586.
22. Lortie M, Beanlands RS, Yoshinaga K, Klein R, Dasilva JN, DeKemp RA,. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging 2007; 34: 1765-1774.
23. Bellina CR, Parodi O, Camici P, et al. Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow. J Nucl Med 1990; 31: 1335-1343.
24. Chen BC, Germano G, Huang SC, et al. A new noninvasive quantification of renal blood-flow with N-13 ammonia, dynamic positron emission tomography, and a 2-compartment model. J Am Soc Nephrol 1992; 3: 1295-1306.
25. Rousset O, Rahmim A, Alavi A, Zaidi H,. Partial volume correction strategies in PET. PET Clin 2007; 2: 235-249.